What determines long-term outcomes using fully bioresorbable scaffolds - the device, the operator or the lesion?
Kyohei Yamaji1, Lorenz Räber, Stephan Windecker
1Department of Cardiology, Bern University Hospital, Bern, Switzerland.
Abstract
No abstract available in PubMed .
More Related Videos
09:49Author Spotlight: Insights into the Use of Apple-Derived Cellulose Scaffolds for Bone Tissue Engineering
Published on: February 23, 2024
2.9K
09:34Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
Published on: September 7, 2017
9.9K
